CompanyGraph
At a glance
- Depends onMidstream position: 5 outgoing, 4 incoming connections
- ScaleMarket cap is $163M, lower than 95% of all stocks globally
- FinancialsAltman Z-Score 0.86: distress zone
- Interpretations1 currently firing — 1
Sign in to view price data.
Sign inThe reported statements, read against the company's own industry.
Financials view
Market Capitalization
163.00MUSDvs all stocks (USD)
Revenue (TTM)
64.68MUSDvs all stocks (USD)
Profit Margin
-14.82%Beta
1.10xvs all stocks
52-Week Change
-4.76%vs all stocks
Market Capitalization
163.00MUSDvs all stocks (USD)
Enterprise Value
166.48MUSDvs all stocks (USD)
Forward P/E
-98.67xPrice to Sales (TTM)
2.52xPrice to Book (MRQ)
5.25xEnterprise to Revenue
2.57xEnterprise to EBITDA
-82.38xGross Margin
61.04%Profit Margin
-14.82%Operating Margin
-9.35%Return on Assets (TTM)
-4.49%Return on Equity (TTM)
-36.62%Revenue (TTM)
64.68MUSDvs all stocks (USD)
Revenue per Share (TTM)
2.52USDUpdated Jul 9, 2026Quarterly Revenue Growth
21.50%Gross Profit (TTM)
42.33MUSDvs all stocks (USD)
EBITDA (TTM)
-2.02MUSDvs all stocks (USD)
Net Income (TTM)
-9.59MUSDvs all stocks (USD)
Quarterly Earnings Growth (YoY)
21.48%Operating Cash Flow (TTM)
-6.70MUSDvs all stocks (USD)
Levered Free Cash Flow (TTM)
-3.30MUSDvs all stocks (USD)
Trailing Annual Dividend Rate
0.00USDUpdated Jul 9, 2026Trailing Annual Dividend Yield
0.00%vs all stocks
Payout Ratio
0.00%Revenue
61.86MUSDFY2025 · Dec 31, 2025Cost of Goods Sold
20.92MUSDFY2025 · Dec 31, 2025Gross Profit
40.93MUSDFY2025 · Dec 31, 2025Operating Income
-8.17MUSDvs all stocks (USD)
Pre-tax Income
-11.37MUSDFY2025 · Dec 31, 2025Income Tax Expense
60.00KUSDFY2025 · Dec 31, 2025Net Income
-11.43MUSDFY2025 · Dec 31, 2025EBIT
-7.67MUSDFY2025 · Dec 31, 2025EBITDA (Income Statement)
-3.24MUSDFY2025 · Dec 31, 2025Research & Development
480.00KUSDFY2025 · Dec 31, 2025Selling, General & Administrative
44.37MUSDFY2025 · Dec 31, 2025Non-operating Interest Income
589.00KUSDFY2025 · Dec 31, 2025Non-operating Interest Expense
3.70MUSDFY2025 · Dec 31, 2025Net Income from Continuing Operations
-11.43MUSDFY2025 · Dec 31, 2025Operating Cash Flow
-22.15MUSDFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
24.09MUSDFY2025 · Dec 31, 2025Income Tax Paid
50.00KUSDFY2025 · Dec 31, 2025Interest Paid
3.24MUSDFY2025 · Dec 31, 2025Starting Profit (CF Statement)
-11.43MUSDFY2025 · Dec 31, 2025Depreciation & Amortization
4.35MUSDFY2025 · Dec 31, 2025Stock-based Compensation
6.29MUSDFY2025 · Dec 31, 2025Other Non-cash Items
466.00KUSDFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
-19.34MUSDFY2025 · Dec 31, 2025Change in Accounts Payable (CF)
-7.20MUSDFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
4.72MUSDFY2025 · Dec 31, 2025Net Intangibles (CF)
0.00USDFY2025 · Dec 31, 2025Long-term Debt Issuance
16.36MUSDFY2025 · Dec 31, 2025Long-term Debt Payments
-625.00KUSDFY2025 · Dec 31, 2025Other Financing Charges
-75.00KUSDFY2025 · Dec 31, 2025Net Financing Cash Flow
15.66MUSDFY2025 · Dec 31, 2025Shares Outstanding
27.33MSharesUpdated Jul 9, 2026Float Shares
14.94MSharesUpdated Jul 9, 2026Shares Short
3.51MSharesUpdated Jul 9, 2026Short Ratio
13.06daysvs all stocks
Short % of Shares Outstanding
23.19%vs all stocks
% Held by Insiders
32.31%vs all stocks
% Held by Institutions
55.81%vs all stocks
Total Cash (MRQ)
27.22MUSDvs all stocks (USD)
Total Cash per Share (MRQ)
0.9890USDUpdated Jul 9, 2026Total Debt (MRQ)
25.47MUSDvs all stocks (USD)
Total Debt to Equity (MRQ)
0.8260xCurrent Ratio (MRQ)
1.72xBook Value per Share (MRQ)
1.13USDUpdated Jul 9, 2026Total Assets
94.59MUSDvs all stocks (USD)
Total Current Assets
66.87MUSDFY2025 · Dec 31, 2025Total Liabilities
62.74MUSDFY2025 · Dec 31, 2025Total Non-current Assets
27.72MUSDFY2025 · Dec 31, 2025Total Non-current Liabilities
25.30MUSDFY2025 · Dec 31, 2025Total Current Liabilities
37.44MUSDFY2025 · Dec 31, 2025Cash & Cash Equivalents
24.09MUSDFY2025 · Dec 31, 2025Accounts Receivable
29.78MUSDFY2025 · Dec 31, 2025Inventory
9.62MUSDFY2025 · Dec 31, 2025Accounts Payable
8.85MUSDFY2025 · Dec 31, 2025Short-term Debt
101.00KUSDFY2025 · Dec 31, 2025Long-term Debt
25.30MUSDFY2025 · Dec 31, 2025Common Stock (Book)
3.00KUSDFY2025 · Dec 31, 2025Retained Earnings
-98.46MUSDFY2025 · Dec 31, 2025Total Shareholders' Equity
31.85MUSDvs all stocks (USD)
52-Week Low
4.31USDUpdated Jul 9, 202652-Week High
9.55USDUpdated Jul 9, 202652-Week Change
-4.76%vs all stocks
Beta
1.10xvs all stocks
50-Day MA
5.63USDUpdated Jul 9, 2026200-Day MA
7.13USDUpdated Jul 9, 2026Avg 10-Day Volume
216.83KSharesUpdated Jul 9, 2026Avg 30-Day Volume
263.56KSharesUpdated Jul 9, 2026Diluted EPS (TTM)
-0.3700USDUpdated Jul 9, 2026Other Income / Expense
-90.00KUSDFY2025 · Dec 31, 20251 interpretation currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsWhere is this company structurally exposed?
Ulcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility Elevated
It sits well below its peak, and the fall has been both deep and long.
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Structural Tensions
High gross margins eroded by operating costsNotable
Gross Margin: 0.61Profit Margin: -0.15
Looks liquid, but the distress score says otherwiseNotable
Current Ratio: 1.72Altman Z-Score: 0.86
Financial Health
Altman Z-Score 0.86: distress zoneCritical
Altman Z-Score: 0.86
Supply Chain
Midstream position: 5 outgoing, 4 incoming connectionsNotable
Outgoing: 5.00Incoming: 4.00
Scale
Market cap is $163M, lower than 95% of all stocks globallySignificant
Market cap (USD): 163,004,518Global P5: 269,387,740.27
Companies that share the same coordination system — how they create, deliver, or capture value.
Alector Inc.
Tier 1ProductionApproval-Gated PipelineRule
Mycenax Biotech Inc.
Tier 1ProductionApproval-Gated PipelineRuleFlow
Sensorion SA
Tier 1ProductionApproval-Gated PipelineRuleRisk
Graphy Inc.
Tier 1ProductionApproval-Gated PipelineRule
Asterasys Co. Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Chill Brands Group Plc
Tier 1ProductionApproval-Gated PipelineRuleFlow
S Biomedics Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRuleRisk
ADC Therapeutics S.A.
Tier 1ProductionApproval-Gated PipelineRule
EKF Diagnostics Holdings plc
Tier 1ProductionApproval-Gated PipelineRuleFlow
HLB Pharmaceutical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRuleFlow
Companies that share active interpretations — structural patterns currently present in both stocks.
Carvana Co.
1 interpretationUlcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility Elevated
Şekerbank T.A.Ş.
1 interpretationUlcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility Elevated
Boku Inc.
1 interpretationUlcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility Elevated